A single center study to examine neural correlates of cognition in subjects with mild Alzheimer's disease after three months of open label donepezil HCl [hydrochloride] (Aricept) treatment

Trial Profile

A single center study to examine neural correlates of cognition in subjects with mild Alzheimer's disease after three months of open label donepezil HCl [hydrochloride] (Aricept) treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jan 2010

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 03 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jun 2008 The expected completion date for this trial is now 1 Aug 2008 as reported by ClinicalTrials.gov.
    • 05 Oct 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top